VACE Advisory · Capability 02
Access
From Regulatory Strategy to Market Access
Two connected components. One Access capability
Regulatory Affairs & Registration
Market Access
Market authorization
Market and patient access
Strategy & Pathways
Regulatory Strategy • Registration Pathway Assessment • Regulatory Intelligence
Strategy & Pricing
Market Access Strategy • Pricing & Reimbursement • HTA / Access Pathway Navigation
Registration & Submissions
Product Registration • Dossier Strategy & Submission Support • Health Authority Engagement • Regional Regulatory Coordination
Payers & Stakeholders
Payer Strategy & Engagement • Access Stakeholder Mapping
Compliance & Lifecycle
Regulatory Compliance • Lifecycle Management • Regulatory Change Management
Institutional & Public Sector
Institutional Access • Formulary Access • Tender & Procurement Strategy • Public-Sector Access
Where relevant to the engagement: Pharmacovigilance & Safety Compliance.
Where access breaks down
Complex pathways & registration delays
Pricing, reimbursement & payer barriers
Disconnected planning
Misalignment between regulatory, access and commercial planning
Unclear regulatory pathways, submission challenges and fragmented requirements across markets
Fragmented payer environments and limited formulary and institutional access

